---
schema_version: "secwatch.filing_event.v1"
accession: "0001829126-24-007372"
form_type: "8-K"
ticker: null
cik: "0000910267"
company_name: "TITAN PHARMACEUTICALS INC"
filed_at: "2024-11-08T23:59:59+00:00"
generated_at: "2026-05-30T03:10:24.058576+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Titan Pharmaceuticals appoints director Brynner Chiam as acting CEO and CFO

## Summary
- Brynner Chiam appointed acting principal executive officer and principal financial officer effective November 6, 2024.
- Company has launched a search for a full-time CEO; Chiam receives no additional compensation.
- Chiam is Tax Director at Black Chamber Management with over 20 years of tax consulting experience.

## SEC filing metadata
- accession: 0001829126-24-007372
- form_type: 8-K
- cik: 0000910267
- company_name: TITAN PHARMACEUTICALS INC
- filed_at: 2024-11-08T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/910267/000182912624007372/0001829126-24-007372-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/910267/000182912624007372/titanpharma_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001829126-24-007372
- JSON: https://secwatch.observer/filing/0001829126-24-007372.json
- Plain text: https://secwatch.observer/filing/0001829126-24-007372.txt

## Key facts
- Executive change
  Brynner Chiam was appointed as acting principal executive officer and acting principal financial officer at TITAN PHARMACEUTICALS INC.
  - Action: appointed
  - Role: acting principal executive officer and acting principal financial officer
  source text: On November 6, 2024, the Board of Directors of Titan Pharmaceuticals, Inc. (the “Company”) appointed Brynner Chiam, a director of the Company, as acting principal executive officer and acting principal financial officer of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/910267/000182912624007372/0001829126-24-007372-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.